These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12678836)

  • 41. Beneficial effects of β-sitosterol on type 1 cholecystokinin receptor dysfunction induced by elevated membrane cholesterol.
    Desai AJ; Dong M; Miller LJ
    Clin Nutr; 2016 Dec; 35(6):1374-1379. PubMed ID: 27016394
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Over-expression of CCK1 Receptor Reverse Morphine Dependence.
    Hao L; Wen D; Gou H; Yu F; Cong B; Ma C
    Int J Pept Res Ther; 2018; 24(3):471-477. PubMed ID: 30147637
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression of cholecystokinin, gastrin, and their receptors in the mouse cornea.
    Gonzalez-Coto AF; Alonso-Ron C; Alcalde I; Gallar J; Meana Á; Merayo-Lloves J; Belmonte C
    Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1965-75. PubMed ID: 24576871
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cholecystokinin but not ghrelin stimulates mucosal bicarbonate secretion in rat duodenum: independence of feeding status and cholinergic stimuli.
    Sjöblom M; Lindqvist R; Bengtsson MW; Jedstedt G; Flemström G
    Regul Pept; 2013 May; 183():46-53. PubMed ID: 23499805
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cholecystokinin (CCK) and related adjunct peptide therapies for the treatment of obesity and type 2 diabetes.
    Pathak V; Flatt PR; Irwin N
    Peptides; 2018 Feb; 100():229-235. PubMed ID: 29412823
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gut vagal afferents are necessary for the eating-suppressive effect of intraperitoneally administered ginsenoside Rb1 in rats.
    Shen L; Wang DQ; Lo CC; Arnold M; Tso P; Woods SC; Liu M
    Physiol Behav; 2015 Dec; 152(Pt A):62-7. PubMed ID: 26384952
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular and functional characterization of cionin receptors in the ascidian, Ciona intestinalis: the evolutionary origin of the vertebrate cholecystokinin/gastrin family.
    Sekiguchi T; Ogasawara M; Satake H
    J Endocrinol; 2012 Apr; 213(1):99-106. PubMed ID: 22289502
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of leptin in the control of feeding of goldfish Carassius auratus: interactions with cholecystokinin, neuropeptide Y and orexin A, and modulation by fasting.
    Volkoff H; Eykelbosh AJ; Peter RE
    Brain Res; 2003 May; 972(1-2):90-109. PubMed ID: 12711082
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of selective CCK receptor agonists on food intake after central or peripheral administration in rats.
    Asin KE; Gore PA; Bednarz L; Holladay M; Nadzan AM
    Brain Res; 1992 Jan; 571(1):169-74. PubMed ID: 1611492
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Peripheral interaction of ghrelin with cholecystokinin on feeding regulation.
    Date Y; Toshinai K; Koda S; Miyazato M; Shimbara T; Tsuruta T; Niijima A; Kangawa K; Nakazato M
    Endocrinology; 2005 Aug; 146(8):3518-25. PubMed ID: 15890776
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Age and nutritional state influence the effects of cholecystokinin on energy balance.
    Balaskó M; Rostás I; Füredi N; Mikó A; Tenk J; Cséplő P; Koncsecskó-Gáspár M; Soós S; Székely M; Pétervári E
    Exp Gerontol; 2013 Nov; 48(11):1180-8. PubMed ID: 23876629
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cholecystokinin: role in thermoregulation and other aspects of energetics.
    Szelényi Z
    Clin Chim Acta; 2010 Mar; 411(5-6):329-35. PubMed ID: 20036221
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The ontogeny of postingestive inhibitory stimuli: examining the role of CCK.
    Weller A
    Dev Psychobiol; 2006 Jul; 48(5):368-79. PubMed ID: 16770766
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Postponement of satiety by blockade of brain cholecystokinin (CCK-B) receptors.
    Dourish CT; Rycroft W; Iversen SD
    Science; 1989 Sep; 245(4925):1509-11. PubMed ID: 2781294
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CCK receptor antagonists.
    Dunlop J
    Gen Pharmacol; 1998 Oct; 31(4):519-24. PubMed ID: 9792209
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CCK1 and 2 receptors are expressed in immortalized rat brain neuroblasts: intracellular signals after cholecystokinin stimulation.
    Langmesser S; Cerezo-Guisado MI; Lorenzo MJ; Garcia-Marin LJ; Bragado MJ
    J Cell Biochem; 2007 Mar; 100(4):851-64. PubMed ID: 17226751
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Baclofen pretreatment attenuates the suppressant effect of intraperitoneal administration of cholecystokinin (CCK) on food intake in rats.
    Ebenezer IS
    Brain Res Bull; 1996; 41(5):269-71. PubMed ID: 8924037
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of cholecystokinin in appetite control and body weight regulation.
    Little TJ; Horowitz M; Feinle-Bisset C
    Obes Rev; 2005 Nov; 6(4):297-306. PubMed ID: 16246215
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Estrogen and CCK1 receptor modification of mu-opioid receptor binding in the cortex of female rats.
    Quesada A; Micevych P
    Brain Res; 2006 Feb; 1073-1074():316-20. PubMed ID: 16472782
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 2-Substituted piperazine-derived imidazole carboxamides as potent and selective CCK1R agonists for the treatment of obesity.
    Berger R; Zhu C; Hansen AR; Harper B; Chen Z; Holt TG; Hubert J; Lee SJ; Pan J; Qian S; Reitman ML; Strack AM; Weingarth DT; Wolff M; Macneil DJ; Weber AE; Edmondson SD
    Bioorg Med Chem Lett; 2008 Sep; 18(17):4833-7. PubMed ID: 18684621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.